Cargando…

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is a prevalent malignancy with a high mortality rate. Cellular senescence, an irreversible state of cell cycle arrest, plays a paradoxical role in cancer progression. Here, we aimed to identify Hepatocellular carcinoma subtypes by cellular senescence-relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yuqin, Guo, Chengbin, Chen, Chuanliang, Zhang, Yongqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800843/ https://www.ncbi.nlm.nih.gov/pubmed/36589233 http://dx.doi.org/10.3389/fmolb.2022.1100285

Ejemplares similares

Mining TCGA Data for Key Biomarkers Related to Immune Microenvironment in Endometrial cancer by Immune Score and Weighted Correlation Network Analysis
por: Guo, Chengbin, et al.
Publicado: (2021)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2022)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Tian, Yilin, et al.
Publicado: (2022)

Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma
por: Liu, Dong-Li, et al.
Publicado: (2022)

Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma
por: Wu, Xiwen, et al.
Publicado: (2021)

Erratum: A metabolism- associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023)

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism
por: Zhang, Hao, et al.
Publicado: (2021)

Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2021)

Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma
por: Li, Muqi, et al.
Publicado: (2020)

A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
por: Kumar, Vinay, et al.
Publicado: (2023)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

A Glycolysis-Related Gene Signature Correlates With the Characteristics of the Tumor Immune Microenvironment and Predicts Prognosis in Patients With Hepatocellular Carcinoma
por: Yang, Jun, et al.
Publicado: (2022)

Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma
por: Wang, Wenjuan, et al.
Publicado: (2022)

Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Zhang, Bo, et al.
Publicado: (2022)

Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2023)

Novel insights into the progression and prognosis of the calpain family members in hepatocellular carcinoma: a comprehensive integrated analysis
por: Dai, Dongjun, et al.
Publicado: (2023)

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma
por: Liu, Lixia, et al.
Publicado: (2021)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023)

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Xuelian, et al.
Publicado: (2022)

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2021)

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer
por: Zhao, Lianfang, et al.
Publicado: (2023)

Identifying Dendritic Cell–Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis
por: Huang, Chaoyuan, et al.
Publicado: (2021)

Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
por: Guo, Chengbin, et al.
Publicado: (2022)

Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma
por: Li, Huihui, et al.
Publicado: (2022)

Editorial: Interventional therapy of hepatocellular carcinoma
por: Ji, Jiansong, et al.
Publicado: (2022)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing
por: Zheng, Su-Su, et al.
Publicado: (2023)

A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer
por: Liu, Jie, et al.
Publicado: (2022)

Cuproptosis patterns in papillary renal cell carcinoma are characterized by distinct tumor microenvironment infiltration landscapes
por: Zhang, Chiyu, et al.
Publicado: (2022)

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
por: Chen, Li, et al.
Publicado: (2021)

An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma
por: Yang, Huixia, et al.
Publicado: (2021)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma
por: Wu, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lelfbp8fmbsdon9onafmt9tf7i